Mustafa N. Yenerel

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Bone Marrow Fibrosis as a Predictor of Extramedullary Disease in Multiple Myeloma.

Bone Marrow Fibrosis as a Predictor of Extramedullary Disease in Multiple Myeloma.

Journal: European journal of haematology

Published: July 22, 2026

IDH1 Mutations in Acute Myeloid Leukemia: Frequency and Clinical Features in the Context of FLT3 and NPM1 Co-Mutations-A Single-Center Study from Turkey.

IDH1 Mutations in Acute Myeloid Leukemia: Frequency and Clinical Features in the Context of FLT3 and NPM1 Co-Mutations-A Single-Center Study from Turkey.

Journal: Current issues in molecular biology

Published: July 05, 2026

Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology.

Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology.

Journal: Journal of clinical medicine

Published: June 24, 2026

Iptacopan monotherapy resulted in increased hemoglobin level in patients with PNH and hemoglobin ≥10 g/dL after anti-C5 therapy.

Iptacopan monotherapy resulted in increased hemoglobin level in patients with PNH and hemoglobin ≥10 g/dL after anti-C5 therapy.

Journal: HemaSphere

Published: February 06, 2026

A Large Room for Improvement in the Management of Relapsed/Refractory Large B-Cell Lymphoma in Türkiye: Real-World Outcomes in a Setting Without Access to T-Cell Redirecting Therapies

A Large Room for Improvement in the Management of Relapsed/Refractory Large B-Cell Lymphoma in Türkiye: Real-World Outcomes in a Setting Without Access to T-Cell Redirecting Therapies

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: November 07, 2025

Pilot evaluation of optical genome mapping in chronic lymphocytic leukemia: complementing FISH analysis.

Pilot evaluation of optical genome mapping in chronic lymphocytic leukemia: complementing FISH analysis.

Journal: BMC cancer

Published: July 21, 2025

Efficacy and safety of vemircopan as monotherapy in patients with paroxysmal nocturnal hemoglobinuria.

Efficacy and safety of vemircopan as monotherapy in patients with paroxysmal nocturnal hemoglobinuria.

Journal: Blood advances

Published: July 11, 2025

Novel prognostic factor in thrombotic thrombocytopenic purpura: human leukocyte antigen class II.

Novel prognostic factor in thrombotic thrombocytopenic purpura: human leukocyte antigen class II.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: April 15, 2025

Therapeutic Challenges and Emerging Strategies for T674I and PTPN11 Mutations in a FIP1L1-PDGFRA-Positive Myeloproliferative Neoplasm: A Case Report.

Therapeutic Challenges and Emerging Strategies for T674I and PTPN11 Mutations in a FIP1L1-PDGFRA-Positive Myeloproliferative Neoplasm: A Case Report.

Journal: Life (Basel, Switzerland)

Published: January 19, 2025

Congenital thrombotic thrombocytopenic purpura and human leukocyte antigen analysis-an amazing clue.

Congenital thrombotic thrombocytopenic purpura and human leukocyte antigen analysis-an amazing clue.

Journal: Hematology, transfusion and cell therapy

Published: October 19, 2024

Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey.

Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: July 31, 2024

Let-7b-5p sensitizes breast cancer cells to doxorubicin through Aurora Kinase B.

Let-7b-5p sensitizes breast cancer cells to doxorubicin through Aurora Kinase B.

Journal: PloS one

Published: July 04, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026